ESG risk score 18.57
Environmental score 2.37
Social score 9.36
Governance score 6.85
ESG risk category Low
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Ypsomed Holding AG
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol YPSN:xswx
Currency CHF
SIX Swiss Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 10.43%
1 year 10.09%
3 years 45.75%
Data provided by 
Key stats
Price/earnings (LTM) 22.21
Dividend yield (LTM) 1.21%
EPS (LTM) 16.31
Volatility (30 days) 32.95%
Data provided by
Analyst consensus
Average rating Overweight
Rating Analysts
Buy
4
Overweight
2
Hold
6
Underweight
0
Sell
1
Target price 394.27
Implied return 8.85%
Last updated 24-Sep-2026
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Ypsomed Holding AG
Ypsomed, based in Burgdorf, Switzerland, develops and manufactures self-injection devices like pens, autoinjectors, and infusion systems for global pharma and biotech companies. The company shifted focus to business-to-business injection systems, divesting its diabetes care segment to supply device platforms to pharma partners.The company operates in a market driven by strong growth in biologics, biosimilars, patient self-administration, and GLP-1 therapies for obesity. To meet demand, Ypsomed has embarked on an ambitious capacity expansion program, with capital expenditure reaching approximately 50% of sales in recent years. This investment is partially derisked through customer co-financing, which aligns incentives and secures future volume commitments before launch.
Sector Healthcare
Industry -
Market cap 4bn
Data provided by /
/ Frequently asked questions
To buy Ypsomed Holding AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ypsomed Holding AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ypsomed Holding AG is YPSN. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ypsomed Holding AG has its primary listing on SIX Swiss Exchange. You can trade Ypsomed Holding AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ypsomed Holding AG is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Ypsomed Holding AG as part of a broader investment portfolio.